Compared with control mice, CRS mice showed significant upregulation of IDO 1 levels in the brain and intestine, facilitated the shift of the TPH metabolic pathway to Kyn signaling, and reversed the anxiety-like behavior of CRS mice after administration of the IDO inhibitor 1-methyltryptophan (1-MT). This evidence concerns the gene IDO1 and congenital rubella syndrome.